Venclexta

Venclexta

Albertsons logo
Albertsons
Pay Online$3,881.51
Walmart logo
Walmart
Pay Online$3,902.04
Walgreens logo
Walgreens
Pay Online$3,903.81
Show this card to your pharmacist

Venclexta Savings card

$3,881.51

BIN
019876
ID
LH46C94594
PCN
CHIPPO
GRP
LHX

Print or send this coupon to your phone

About Venclexta

Drug Details

Venetoclax, marketed under the name Venclexta, is a medication primarily used to treat certain blood and lymph node cancers such as acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL). It is particularly prescribed for older adults or individuals with specific medical conditions. This medication is typically taken orally once a day, either alone or alongside other chemotherapy or targeted treatments, depending on the patient's specific condition. Venclexta operates as a targeted therapy known as a BCL-2 inhibitor. The BCL-2 protein aids in the survival of cancer cells, and certain cancers, including AML and CLL/SLL, are characterized by an overproduction of this protein, leading to uncontrolled cell growth. By blocking BCL-2, venetoclax helps to kill and slow the growth of these cancer cells, effectively managing the disease. Patients should be aware that venetoclax can increase the risk of a serious condition known as tumor lysis syndrome (TLS). It is crucial to engage with healthcare professionals, such as doctors, nurses, or pharmacists, to receive personalized medical advice and ensure the medication's safe and effective use.

Price history for Venclexta

28 Tablets, 100MG

Average retail price for Venclexta

Average SaveHealth price for Venclexta

Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.

*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.

Related Prescriptions

Venclexta dosage forms

DosageQuantityPrice fromPer unit
10MG2 Tablets$33.83$16.92
10MG14 Tablets$200.74$14.34
50MG1 Tablet$75.60$75.60
50MG7 Tablets$492.30$70.33
100MG28 Tablets$3,881.51$138.63
100MG1 Tablet$145.15$145.15
100MG120 Tablets$16,608.75$138.41

Venclexta FAQs

VENCLEXTA (venetoclax) is not considered traditional chemotherapy. It is a targeted therapy known as a BCL-2 inhibitor, which works by helping to restore the process of apoptosis, or programmed cell death, in cancer cells.

VENCLEXTA is used for the treatment of certain types of blood cancers, specifically chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and acute myeloid leukemia (AML). It works by targeting and inhibiting a protein that helps cancer cells survive, thereby promoting their destruction.

VENCLEXTA (venetoclax) is not classified as an immunosuppressant. It is a medication used primarily in the treatment of certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). It works by inhibiting a protein called BCL-2, which helps cancer cells survive.

The life expectancy of patients taking VENCLEXTA (venetoclax) can vary significantly based on several factors, including the type and stage of cancer being treated, the patient's overall health, response to treatment, and other individual circumstances. Clinical trials and studies provide data on progression-free survival and overall survival rates, but these are averages and may not predict individual outcomes. It is important for patients to discuss their specific prognosis with their healthcare provider, who can provide information tailored to their unique situation.

Venetoclax is not classified as an immunosuppressant. It is a medication used primarily in the treatment of certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). It works by inhibiting the BCL-2 protein, which helps cancer cells survive.

Read All FAQs